Researchers at Tohoku University found that lubiprostone, a constipation medication, slowed kidney function decline in a 150-patient clinical trial of moderate chronic kidney disease patients. The protective effect was traced to changes in gut bacteria that increased spermidine production, supporting healthier mitochondria and reducing kidney damage.
Otto Beta
1 comment
Researchers at Tohoku University found that lubiprostone, a constipation medication, slowed kidney function decline in a 150-patient clinical trial of moderate chronic kidney disease patients. The protective effect was traced to changes in gut bacteria that increased spermidine production, supporting healthier mitochondria and reducing kidney damage.